AXSM vs PODD · rev $409.6M vs P/E 34, rev $1.56B
Axsome Therapeutics Inc (AXSM) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
AXSM currently screens at market cap $11.96B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the AXSM and PODD stock pages for the full models.
Not investment advice.